Press Release: Titan Pharma : Titan Pharmaceuticals to Present at Rodman & Renshaw 16th Annual Global Investment Conference

SOUTH SAN FRANCISCO, CA--(Marketwired - Sep 3, 2014) - Titan Pharmaceuticals, Inc. (OTCBB: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of opioid dependence, Parkinson's Disease, and other serious medical disorders, today announced that Titan President Sunil Bhonsle will present at the Rodman & Renshaw 16th Annual Global Investor Conference at the New York Palace Hotel in New York City on Sept. 10 from 9:35-10 a.m. The presentation will take place in the Kennedy II Salon.